Orythia Pain Relieving Lidocaine

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Orythia Pain Relieving Lidocaine
Generic name
LIDOCAINE
Manufacturer
Planet (Anhui) Pharmaceutical Co., Ltd.
Product type
HUMAN OTC DRUG
SPL set ID
d658d495-dd2c-40b7-9446-6f10040ed55e
SPL ID
3893145a-25e7-9678-e063-6294a90aa827
Version
1
Effective date
2025-06-27
Source export date
2026-11-06
Source partition
4
Source file
https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-06/b00a73f24c6ff050408c570063640e3d80d1f71dfc9a165d1cf072a25659445a/drug-label-0004-of-0014.json.zip
Source manifest SHA-256
4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run
20261108T063105Z
Imported at
2026-11-08 07:02:37
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS For external us only Do not use • more than 1 patch at a time • with a heating pad • on wounds or damaged skin • if you are allergic to any ingredients of this product When using this product • use only as directed • do not bandage tightly • avoid contact with the eyes, mucous membranes or rashes Stop use and ask a doctor if • symptoms persist for more than 7 days • conditions worsen • sympotms clear up and occur again within a few days • localized skin reactions, such as rash, itching, redness, pain, swelling and blistering develop If pregnant or breast feeding, ask a health professional before use Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.